18485101|t|Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway.
18485101|a|Amyloid-beta (Abeta) accumulation and fibril formation are key pathologic characteristics of Alzheimer's disease (AD). We have previously found that sulfatide depletion occurs at the earliest stages of AD. To further identify the role of sulfatides in the pathogenesis of AD as well as the interactions between apolipoprotein E (apoE), sulfatides, and Abeta peptides, we examined alterations in the clearance of apoE-mediated Abeta peptides after sulfatide supplementation to cell culture systems. We demonstrated that sulfatides markedly facilitate apoE-mediated clearance of Abeta peptides endogenously generated from H4-APPwt cells through an endocytotic pathway. Moreover, we found that the uptake of Abeta42 mediated by sulfatides was selective in comparison to that of Abeta40. We excluded the possibility that the supplementation of sulfatides and/or apoE altered the production of Abeta peptides from H4-APPwt cells through determination of the clearance of Abeta peptides from conditioned H4-APPwt cell media by neuroblastoma cells which do not appreciably generate Abeta peptides. Finally, we demonstrated that the sulfate galactose moiety of sulfatides is essential for the sulfatide-facilitated clearance of Abeta peptides. Collectively, the current study provides insight into a molecular mechanism leading to Abeta clearance/deposition, highlights the significance of sulfatide deficiency at the earliest clinically recognizable stage of AD, and identifies a potential new direction for therapeutic intervention for the disease.
18485101	0	10	Sulfatides	Chemical	MESH:D013433
18485101	22	38	apolipoprotein E	Gene	348
18485101	111	123	Amyloid-beta	Gene	351
18485101	125	130	Abeta	Gene	351
18485101	204	223	Alzheimer's disease	Disease	MESH:D000544
18485101	225	227	AD	Disease	MESH:D000544
18485101	260	269	sulfatide	Chemical	MESH:D013433
18485101	313	315	AD	Disease	MESH:D000544
18485101	349	359	sulfatides	Chemical	MESH:D013433
18485101	383	385	AD	Disease	MESH:D000544
18485101	422	438	apolipoprotein E	Gene	348
18485101	440	444	apoE	Gene	348
18485101	447	457	sulfatides	Chemical	MESH:D013433
18485101	463	468	Abeta	Gene	351
18485101	523	527	apoE	Gene	348
18485101	537	542	Abeta	Gene	351
18485101	558	567	sulfatide	Chemical	MESH:D013433
18485101	630	640	sulfatides	Chemical	MESH:D013433
18485101	661	665	apoE	Gene	348
18485101	688	693	Abeta	Gene	351
18485101	731	739	H4-APPwt	CellLine	CVCL:JF98
18485101	816	823	Abeta42	Gene	351
18485101	836	846	sulfatides	Chemical	MESH:D013433
18485101	951	961	sulfatides	Chemical	MESH:D013433
18485101	969	973	apoE	Gene	348
18485101	1000	1005	Abeta	Gene	351
18485101	1020	1028	H4-APPwt	CellLine	CVCL:JF98
18485101	1077	1082	Abeta	Gene	351
18485101	1109	1117	H4-APPwt	CellLine	CVCL:JF98
18485101	1186	1191	Abeta	Gene	351
18485101	1236	1253	sulfate galactose	Chemical	-
18485101	1264	1274	sulfatides	Chemical	MESH:D013433
18485101	1296	1305	sulfatide	Chemical	MESH:D013433
18485101	1331	1336	Abeta	Gene	351
18485101	1434	1439	Abeta	Gene	351
18485101	1493	1502	sulfatide	Chemical	MESH:D013433
18485101	1563	1565	AD	Disease	MESH:D000544
18485101	Association	MESH:D013433	348
18485101	Association	348	351
18485101	Negative_Correlation	MESH:D013433	351
18485101	Association	MESH:D000544	351
18485101	Negative_Correlation	MESH:D013433	MESH:D000544

